DRREDDY vs TATACONSUM: Stock Comparison
DR. REDDY S LABORATORIES is the larger company by market capitalisation. DR. REDDY S LABORATORIES shows a lower P/E, a higher ROE and a higher ROCE, while TATA CONSUMER PRODUCT shows a higher dividend yield, faster revenue growth and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
DRREDDY leads 7; TATACONSUM leads 6 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | DRREDDY | TATACONSUM |
|---|---|---|
| Sector | Healthcare | Fast Moving Consumer Goods |
| Industry | Pharmaceuticals | Tea & Coffee |
Price
| Metric | DRREDDY | TATACONSUM |
|---|---|---|
| Live Price | ₹1,208 | ₹976 |
| Day Change | 0.42% | 2.33% |
| Volume | 16.38 L | 9.04 L |
| 52-Week High | ₹1,414.9 | ₹1,282.7 |
| 52-Week Low | ₹1,101 | ₹945 |
| Distance from 52W High | -14.62% | -23.91% |
Valuation
| Metric | DRREDDY | TATACONSUM |
|---|---|---|
| Market Cap | ₹1.01 L Cr | ₹96,490 Cr |
| P/E Ratio | 31.29x | 57.77x |
| P/B Ratio | 2.66x | 4.33x |
| EPS | ₹39.74 | ₹16.52 |
| Book Value | ₹460.31 | ₹220.17 |
| Dividend Yield | 0.66% | 1.04% |
Growth
| Metric | DRREDDY | TATACONSUM |
|---|---|---|
| Revenue Growth (TTM YoY) | -11.6% | 17.9% |
| EPS Growth (TTM YoY) | -86.2% | 21.5% |
| Qtr Sales Growth | -36.58% | -24.69% |
| Qtr Profit Growth | -7.09% | 67.2% |
Profitability & Leverage
| Metric | DRREDDY | TATACONSUM |
|---|---|---|
| ROE | 10.27% | 6.67% |
| ROCE | 9.14% | 7.82% |
| Net Margin | 12.76% | 7.44% |
| Operating Margin | 21.43% | 11.38% |
| Debt to Equity | 0.17x | 0.09x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | DRREDDY | TATACONSUM |
|---|---|---|
| Promoter Holding | 26.64%▲ 0.01 pp | 33.83% |
| FII Holding | 32.07%▼ 1.01 pp | 20.08%▼ 0.71 pp |
| DII Holding | 31.74%▲ 1.02 pp | 25.01%▲ 0.82 pp |
| Public Holding | 9.35%▲ 0.02 pp | 21.07%▼ 0.11 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: DR. REDDY S LABORATORIES and TATA CONSUMER PRODUCT.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.